Point72 Hong Kong’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,006	Closed	-$28K	–	1652
2022 Q2	$28K	Buy	+1,006	New	+$28K	﹤0.01%	1040
2022 Q1	–	Sell	-198	Closed	-$12K	–	1590
2021 Q4	$12K	Buy	+198	New	+$12K	﹤0.01%	1070